IceCure Medical Statistics
Total Valuation
IceCure Medical has a market cap or net worth of $26.25 million. The enterprise value is $17.57 million.
Important Dates
The next estimated earnings date is Wednesday, May 27, 2026, before market open.
| Earnings Date | May 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
IceCure Medical has 81.18 million shares outstanding. The number of shares has increased by 24.97% in one year.
| Current Share Class | 81.18M |
| Shares Outstanding | 81.18M |
| Shares Change (YoY) | +24.97% |
| Shares Change (QoQ) | +11.05% |
| Owned by Insiders (%) | 46.46% |
| Owned by Institutions (%) | 0.70% |
| Float | 43.47M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.77 |
| Forward PS | 3.24 |
| PB Ratio | 2.61 |
| P/TBV Ratio | 2.90 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.20 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.61, with a Debt / Equity ratio of 0.02.
| Current Ratio | 2.61 |
| Quick Ratio | 1.96 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -188.78% and return on invested capital (ROIC) is -113.47%.
| Return on Equity (ROE) | -188.78% |
| Return on Assets (ROA) | -71.29% |
| Return on Invested Capital (ROIC) | -113.47% |
| Return on Capital Employed (ROCE) | -166.53% |
| Weighted Average Cost of Capital (WACC) | 17.95% |
| Revenue Per Employee | $48,971 |
| Profits Per Employee | -$218,217 |
| Employee Count | 69 |
| Asset Turnover | 0.26 |
| Inventory Turnover | 0.93 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -71.64% in the last 52 weeks. The beta is 2.52, so IceCure Medical's price volatility has been higher than the market average.
| Beta (5Y) | 2.52 |
| 52-Week Price Change | -71.64% |
| 50-Day Moving Average | 0.55 |
| 200-Day Moving Average | 0.77 |
| Relative Strength Index (RSI) | 29.68 |
| Average Volume (20 Days) | 881,539 |
Short Selling Information
The latest short interest is 698,280, so 0.86% of the outstanding shares have been sold short.
| Short Interest | 698,280 |
| Short Previous Month | 611,285 |
| Short % of Shares Out | 0.86% |
| Short % of Float | 1.61% |
| Short Ratio (days to cover) | 2.94 |
Income Statement
In the last 12 months, IceCure Medical had revenue of $3.38 million and -$15.06 million in losses. Loss per share was -$0.24.
| Revenue | 3.38M |
| Gross Profit | 1.23M |
| Operating Income | -15.09M |
| Pretax Income | -15.06M |
| Net Income | -15.06M |
| EBITDA | -14.80M |
| EBIT | -15.09M |
| Loss Per Share | -$0.24 |
Full Income StatementBalance Sheet
The company has $8.90 million in cash and $217,000 in debt, with a net cash position of $8.68 million or $0.11 per share.
| Cash & Cash Equivalents | 8.90M |
| Total Debt | 217,000 |
| Net Cash | 8.68M |
| Net Cash Per Share | $0.11 |
| Equity (Book Value) | 9.05M |
| Book Value Per Share | 0.12 |
| Working Capital | 7.78M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$14.57 million and capital expenditures -$36,000, giving a free cash flow of -$14.61 million.
| Operating Cash Flow | -14.57M |
| Capital Expenditures | -36,000 |
| Depreciation & Amortization | 295,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -14.61M |
| FCF Per Share | -$0.18 |
Full Cash Flow StatementMargins
| Gross Margin | 36.28% |
| Operating Margin | -446.70% |
| Pretax Margin | -445.61% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
IceCure Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -24.97% |
| Shareholder Yield | n/a |
| Earnings Yield | -57.37% |
| FCF Yield | -55.67% |
Analyst Forecast
The average price target for IceCure Medical is $2.50, which is 673.28% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $2.50 |
| Price Target Difference | 673.28% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 100.36% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IceCure Medical has an Altman Z-Score of -7.04 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -7.04 |
| Piotroski F-Score | 3 |
